A NOVEL AUTOMATED IMMUNOASSAY FOR ANTI-NEPHRIN AUTOANTIBODIES USING A MUTANT NEPHRIN ANTIGEN

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/821c804925c833f1910417e67be24dc5.pdf
A NOVEL AUTOMATED IMMUNOASSAY FOR ANTI-NEPHRIN AUTOANTIBODIES USING A MUTANT NEPHRIN ANTIGEN

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Masaya
Muto
Masaya Muto Muto.Masaya@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan *
Tomoko Horinouchi tohori@med.kobe-u.ac.jp Kobe University Graduate School of Medicine Department of Pediatrics Kobe Japan -
Yumiko Sakai Sakai.Yumiko@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan -
Jeeeun Kim Kim.Jeeeun@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan -
Aoi Tanaka Tanaka.Aoi.1@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan -
Eri Yamamoto Yamamoto.Eri@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan -
Akshay Ganguly Ganguly.Akshay@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan -
Yuta Inoki inoki2y@med.kobe-u.ac.jp Kobe University Graduate School of Medicine Department of Pediatrics Kobe Japan -
China Nagano china@med.kobe-u.ac.jp Kobe University Graduate School of Medicine Department of Pediatrics Kobe Japan -
Takaya Ozeki ozeki20@med.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Department of Nephrology Nagoya Japan -
Shoichi Maruyama marus@med.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Department of Nephrology Nagoya Japan -
Yoshitaka Isaka isaka@kid.med.osaka-u.ac.jp The University of Osaka Graduate School of Medicine Department of Nephrology Osaka Japan -
Kandai Nozu nozu@med.kobe-u.ac.jp Kobe University Graduate School of Medicine Department of Pediatrics Kobe Japan -
Kazumoto Iijima iijima@med.kobe-u.ac.jp Hyogo Prefectural Kobe Children's Hospital Department of Nephrology Kobe Japan -
Amane Harada Harada.Amane@sysmex.co.jp Sysmex Corporation Central Research Laboratories Kobe Japan -